查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1406902

海洋生物技术：市场占有率分析、产业趋势/统计、成长预测，2024-2029

Marine Biotechnology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

海洋生物技术市场预计在预测期内复合年增长率为8.5%。

COVID-19大流行影响了海洋生物技术产业的阶段需求和生产。同时，这场大流行支持了海洋补充品的生产，因为它们可以提供 COVID-19 感染的潜在健康益处。例如，根据 2022 年 2 月发表在《抗氧化剂杂誌》上的一篇论文，几种海藻物种被用作具有潜在抗病毒和免疫调节作用的生物活性代谢物。因此，在大流行期间，海洋补充品的使用量激增，极大地影响了市场成长。然而，随着COVID-19感染数量的下降，海洋生物技术市场稳定成长，预计在预测期内也将出现类似的成长。

海洋生物技术-市场-IMG1

藻类和真菌等海洋生物在药品、化妆品、食品、农业等各行业的使用量不断增加，是推动海洋生物技术市场成长的主要因素。例如，2021年7月，印度国家海洋技术研究所的一群科学家借助深海细菌开发了一种用于製作化妆品的抗老化成分。此外，美国、德国和英国等已开发国家对海洋营养补充的需求食品增加。根据2022年2月发表在《海洋科学前沿杂誌》上的一篇论文，已知某些在恶劣环境条件下繁衍生息的海洋微生物含有抗氧化、抗菌、凋亡、抗肿瘤和抗病毒物质，可用于生产机能性食品成分用于维持健康及预防慢性疾病。在食品营养补充生产中增加利用海洋资源预计将在预测期内推动市场成长。此外，建议婴儿和婴幼儿摄取高水平的多元不用餐多不饱和脂肪酸。这些健康的脂肪酸是由海洋微藻类大量产生的。渔业、药物研发和水产养殖领域的进步，以及人们对海洋生物开拓的潜力及其在各行业中的应用的日益认识，预计将很快增加对海洋生物技术来源的需求。

然而，缺乏海洋探勘以及在实验室条件下培养海洋微生物的能力有限可能会限制预测期内的市场成长。

海洋生物技术市场趋势

医疗与製药部门预计在预测期内将显着成长

在分析期间，医疗和製药领域预计将占据重要的市场占有率。微生物源药物现在越来越多地用于治疗感染疾病和慢性病。最常用的微生物製剂有青霉素、放线菌素、头孢菌素、链霉素和Cyclosporine。

增加与利用海洋生物生产针对各种疾病的各种治疗药物相关的研究活动预计将促进该领域的成长。例如，2021 年 1 月，加州大学的科学家在海洋环境中发现了结构多样的天然化合物。这些化合物预计可用于开发抗病毒疗法。此外，根据 2022 年 3 月发表在《医疗保健生物技术》杂誌上的一项研究，海藻具有近 11,000 种具有营养和药理特性的天然益处。从微藻类和大型藻类中发现的许多化合物具有重要的药理特性，例如抗菌、抗真菌、抗病毒、抗疱疹、抗氧化和降血糖特性。

科技进步提高了我们养殖海洋生物的能力。例如，2021年4月，日本科学家首次成功培育出稳定的珊瑚细胞株。这些进步和在製药工业中使用海洋生物的研究活动的增加预计将为从海洋生物生产各种生医材料开闢新的途径。反过来，这可能会推动医疗和製药业对海洋生物技术的需求。

海洋生物技术-市场-IMG2

预计在预测期内欧洲将占据海洋生物技术市场的主要份额

预计欧洲将在整个预测期内占据重要的市场占有率。政府对促进天然海鲜产品利用的支持以及这些产品市场开拓资金筹措将支持预测期内德国市场的成长。例如，2021 年 3 月，德国生技公司 Bluu Biosciences 获得了约 700 万欧元（780 万美元）的资金，用于利用细胞培养生产高品质、永续的鱼产品。

先进的医疗基础设施、海洋生物技术的进步以及製药和化妆品行业对海洋生物不断增长的需求是欧洲对海洋生物技术的高需求背后的主要因素。例如，2021年3月，Sea4Us计划借助海洋生物製品开发一种非阿片类镇痛药的慢性疼痛治疗​​方法。该公司参与了欧盟委员会支持的多个计划。

因此，上述因素以及欧洲大规模海水养殖业务预计将推动欧洲市场的成长。

海洋生物技术产业概况

海洋生物技术市场竞争中等，由多家大公司组成，例如BASF SE、AstaReal、Aker Biomarine、Euglena、Cyanotech Corporation 和 Earthrise Nutritionals LLC。

其他福利：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场动态

  • 市场概况
  • 市场驱动因素
    • 製药和化妆品行业更多地使用海洋生物
    • 对海洋营养补充食品的需求不断增加
    • 渔业和药物研发领域的进展
  • 市场抑制因素
    • 缺乏海洋探勘
    • 实验室培养海洋微生物能力的限制
  • 波特五力分析
    • 供应商的议价能力
    • 买家/消费者的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间敌对关係的强度

第五章市场区隔

  • 按产地
    • 珊瑚和海绵
    • 藻类
    • 海洋病毒
    • 海洋真菌
    • 其他产地
  • 按最终用户
    • 医疗/製药
    • 食品工业
    • 化妆品产业
    • 化学工业
    • 其他最终用户
  • 地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 其他欧洲国家
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳洲
      • 韩国
      • 其他亚太地区
    • 中东/非洲
      • GCC
      • 南非
      • 其他中东/非洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区

第六章 竞争形势

  • 公司简介
    • BASF SE
    • AstaReal Co., Ltd.
    • Aker Biomarine
    • Euglena Co.,Ltd.
    • Cyanotech Corporation
    • Earthrise Nutritionals LLC
    • CP Kelco US, Inc
    • Bluebiotech International GmbH
    • Marinomed Biotech AG
    • PharmaMar SA

第七章 市场机会及未来趋势

简介目录
Product Code: 72468
Marine Biotechnology - Market - IMG1

The marine biotechnology market is expected to register a CAGR of 8.5% over the forecast period.

The COVID-19 pandemic affected demand and production in the marine biotechnology industry during the initial phase. On the other hand, the pandemic aided the production of marine-derived supplements since they provided potential health benefits against the COVID-19 infection. For instance, as per the article published in the Journal of Antioxidants in February 2022, several marine algae species have been utilized for their bioactive metabolites with potential antiviral and immunomodulatory activities. Thus, the surging use of marine-derived supplements during the pandemic significantly impacted the market growth. However, with the decrease in number of COVID-19 cases, the marine biotechnology market has gained stable growth and is expected to do the same during the forecast period.

The increase in the usage of marine organisms, such as algae and fungi, in different industries, such as pharmaceuticals, cosmetics, food, and agriculture, is a major factor boosting the growth of the marine biotechnology market. For instance, in July 2021, a team of scientists from the National Institute of Ocean Technology, India, developed an anti-ageing ingredient for making cosmetics with the help of deep-sea bacteria. Furthermore, there is an increasing demand for marine-derived nutritional supplements in developed countries such as the United States, Germany, and the United Kingdom. According to an article published in the Journal of Frontiers in Marine Science in February 2022, certain marine microbes which thrive in harsh environmental conditions produce antioxidant, antibacterial, apoptotic, antitumoral, and antiviral chemicals, which could be used in the production of functional food ingredients for health maintenance and chronic disease prevention. The rise in the utilization of marine resources for the production of nutritional supplements is expected to add to the market's growth during the forecast period. Moreover, high dietary levels of polyunsaturated fatty acids are recommended for infants. These healthy fatty acids are produced in large quantities by marine microalgal species. Advancements in the fields of fisheries, drug discovery, and aquaculture and an increase in awareness regarding the untapped potential and use of marine organisms in different industries are expected to increase demand for marine biotechnology sources shortly.

However, the lack of exploration of the oceans and the limited ability to culture marine microorganisms in laboratory conditions will likely restrict the market's growth during the forecast period.

Marine Biotechnology Market Trends

The Medical and Pharmaceutical Segment is Expected to Register the Significant Growth Over the Forecast Period

The medical and pharmaceutical segment is anticipated to hold a significant market share over the analysis period. Currently, microbially derived drugs are increasingly being used in the treatment of infectious diseases and chronic diseases. The most commonly used microbially derived drugs are penicillin, actinomycin, cephalosporins, streptomycin, and cyclosporin.

The increase in research activities related to using marine organisms to produce different therapeutics for various diseases is expected to boost the segment's growth. For instance, in January 2021, scientists at the University of California identified structurally diverse natural compounds in the marine environment. These compounds are expected to help in the development of antiviral therapeutics. Moreover, according to the study published in Biotechnology in Healthcare Journal in March 2022, nearly 11,000 natural effects with nutrition and pharmacological properties have been reported in marine algae. Many compounds found in micro and macroalgae have critical pharmacological properties, such as antibacterial, antifungal, antiviral, antiherpetic, antioxidative, and hypoglycemic properties.

With the advancement in technology, the ability to culture marine organisms has improved. For instance, in April 2021, scientists in Japan successfully cultured the first stable coral cell lines. Such advancement and increased research activities related to using marine organisms in the pharmaceutical industry are expected to open new avenues for producing different biomaterials from marine organisms. This, in turn, can promote the demand for marine biotechnology in the medical and pharmaceutical industries.

Marine Biotechnology - Market - IMG2

Europe is Expected to Hold a Significant Share in the Marine Biotechnology Market Over the Forecast Period

Europe is expected to hold a significant market share throughout the forecast period. The government's support to promote the use of natural marine products and the availability of funding for developing these products will help boost the market growth in Germany during the forecast period. For instance, in March 2021, Bluu Biosciences, a German-based biotech firm, received almost EUR 7 million (USD 7.8 million) to produce high-quality, sustainable fish products from cell cultures.

The presence of sophisticated healthcare infrastructure, technological advancements in marine biotechnology, and the growing demand for marine organisms in the pharmaceutical and cosmetic industries are major factors for the high demand for marine biotechnology in Europe. For instance, in March 2021, Sea4Us planned on developing a remedy for chronic pain, a non-opioid analgesic, with the help of marine bioproducts. The company has worked on many European Commission-supported projects.

Hence, the factors mentioned above and the large marine-farming operations in Europe are expected to boost the market's growth in Europe.

Marine Biotechnology Industry Overview

The marine biotechnology market is moderately competitive and consists of a large number of major players, including BASF SE, AstaReal Co., Ltd., Aker Biomarine, Euglena Co., Ltd., Cyanotech Corporation, and Earthrise Nutritionals LLC, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in the Usage of Marine Organisms in the Pharmaceutical and Cosmetic Industries
    • 4.2.2 Increasing Demand for Marine-Derived Nutritional Supplements
    • 4.2.3 Advancements in the Field of Fisheries and Drug Discovery
  • 4.3 Market Restraints
    • 4.3.1 Lack of Exploration in Oceans
    • 4.3.2 Limited Ability to Culture Marine Micro-organisms in Laboratories
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Source
    • 5.1.1 Corals and Sponges
    • 5.1.2 Algae
    • 5.1.3 Marine Viruses
    • 5.1.4 Marine Fungi
    • 5.1.5 Other Sources
  • 5.2 By End User
    • 5.2.1 Medical and Pharmaceutical
    • 5.2.2 Food Industry
    • 5.2.3 Cosmetics Industry
    • 5.2.4 Chemical Industry
    • 5.2.5 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 BASF SE
    • 6.1.2 AstaReal Co., Ltd.
    • 6.1.3 Aker Biomarine
    • 6.1.4 Euglena Co.,Ltd.
    • 6.1.5 Cyanotech Corporation
    • 6.1.6 Earthrise Nutritionals LLC
    • 6.1.7 CP Kelco U.S., Inc
    • 6.1.8 Bluebiotech International GmbH
    • 6.1.9 Marinomed Biotech AG
    • 6.1.10 PharmaMar SA

7 MARKET OPPORTUNITIES AND FUTURE TRENDS